• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006-2017 年英国英格兰肠道病毒 A71 和柯萨奇病毒 A6 流行情况:使用横断面血清流行率数据的数学建模研究。

Enterovirus A71 and coxsackievirus A6 circulation in England, UK, 2006-2017: A mathematical modelling study using cross-sectional seroprevalence data.

机构信息

Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Department of Mathematics, College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, United Kingdom.

出版信息

PLoS Pathog. 2024 Nov 20;20(11):e1012703. doi: 10.1371/journal.ppat.1012703. eCollection 2024 Nov.

DOI:10.1371/journal.ppat.1012703
PMID:39565769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11578500/
Abstract

Enterovirus A71 (EV-A71) and coxsackievirus A6 (CVA6) primarily cause hand, foot and mouth disease and have emerged to cause potential fatal neurological and systemic manifestations. However, limited surveillance data collected through passive surveillance systems hampers characterization of their epidemiological dynamics. We fit a series of catalytic models to age-stratified seroprevalence data for EV-A71 and CVA6 collected in England at three time points (2006, 2011 and 2017) to estimate the force of infection (FOI) over time and assess possible changes in transmission. For both serotypes, model comparison does not support the occurrence of important changes in transmission over the study period, and we find that a declining risk of infection with age and / or seroreversion are needed to explain the seroprevalence data. Furthermore, we provide evidence that the increased number of reports of CVA6 during 2006-2017 is unlikely to be explained by changes in surveillance. Therefore, we hypothesize that the increased number of CVA6 cases observed since 2011 must be explained by increased virus pathogenicity. Further studies of seroprevalence data from other countries would allow to confirm this. Our results underscore the value of seroprevalence data to unravel changes in the circulation dynamics of pathogens with weak surveillance systems and large number of asymptomatic infections.

摘要

肠道病毒 A71(EV-A71)和柯萨奇病毒 A6(CVA6)主要引起手足口病,并已出现导致潜在致命的神经和全身表现的情况。然而,通过被动监测系统收集的有限监测数据阻碍了对其流行病学动态的特征描述。我们对在英格兰三个时间点(2006 年、2011 年和 2017 年)收集的针对 EV-A71 和 CVA6 的按年龄分层血清流行率数据拟合了一系列催化模型,以估计随时间推移的感染力(FOI)并评估可能发生的传播变化。对于这两种血清型,模型比较均不支持在研究期间发生重要的传播变化,我们发现需要降低感染风险的年龄和/或血清学逆转才能解释血清流行率数据。此外,我们提供的证据表明,2006 年至 2017 年期间 CVA6 报告病例数的增加不太可能是由于监测变化引起的。因此,我们假设自 2011 年以来观察到的 CVA6 病例数的增加必须归因于病毒致病性的增加。对来自其他国家的血清流行率数据的进一步研究将能够证实这一点。我们的研究结果强调了血清流行率数据对于在具有较弱监测系统和大量无症状感染的情况下揭示病原体循环动力学变化的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/22c068a3eddb/ppat.1012703.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/7898eaa7e2dd/ppat.1012703.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/706265467dcd/ppat.1012703.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/4fb96eb1ece5/ppat.1012703.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/a55b8e63f83b/ppat.1012703.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/933dea0cf94c/ppat.1012703.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/22c068a3eddb/ppat.1012703.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/7898eaa7e2dd/ppat.1012703.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/706265467dcd/ppat.1012703.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/4fb96eb1ece5/ppat.1012703.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/a55b8e63f83b/ppat.1012703.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/933dea0cf94c/ppat.1012703.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abee/11578500/22c068a3eddb/ppat.1012703.g006.jpg

相似文献

1
Enterovirus A71 and coxsackievirus A6 circulation in England, UK, 2006-2017: A mathematical modelling study using cross-sectional seroprevalence data.2006-2017 年英国英格兰肠道病毒 A71 和柯萨奇病毒 A6 流行情况:使用横断面血清流行率数据的数学建模研究。
PLoS Pathog. 2024 Nov 20;20(11):e1012703. doi: 10.1371/journal.ppat.1012703. eCollection 2024 Nov.
2
Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017.血清流行率和肠病毒 71 型和柯萨奇病毒 A6 的病毒学监测,英国,2006-2017 年。
Emerg Infect Dis. 2021 Sep;27(9):2261-2268. doi: 10.3201/eid2709.204915.
3
Seroprevalence of coxsackievirus A6 and enterovirus A71 infection in humans: a systematic review and meta-analysis.柯萨奇病毒 A6 和肠道病毒 A71 感染在人类中的血清流行率:系统评价和荟萃分析。
Arch Virol. 2023 Jan 7;168(2):37. doi: 10.1007/s00705-022-05642-0.
4
Clinical features of hand, foot and mouth disease caused by Coxsackievirus A6 in Xi'an, China, 2013-2019: A multicenter observational study.2013-2019 年中国西安柯萨奇病毒 A6 引起的手足口病的临床特征:一项多中心观察性研究。
Acta Trop. 2024 Sep;257:107310. doi: 10.1016/j.actatropica.2024.107310. Epub 2024 Jun 30.
5
Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China.中国山东省健康人群中肠道病毒A71型和柯萨奇病毒A16型的血清流行率
PLoS One. 2016 Sep 9;11(9):e0162373. doi: 10.1371/journal.pone.0162373. eCollection 2016.
6
Genomic epidemiology of CVA10 in Guangdong, China, 2013-2021.中国广东 2013-2021 年 CVA10 的基因组流行病学研究。
Virol J. 2024 May 30;21(1):122. doi: 10.1186/s12985-024-02389-9.
7
Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.中国的手足口病:肠道病毒血清型流行动态建模及疫苗接种的意义
PLoS Med. 2016 Feb 16;13(2):e1001958. doi: 10.1371/journal.pmed.1001958. eCollection 2016 Feb.
8
[Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].基于2011 - 2015年广东省主动监测的手足口病肠道病毒71型病例流行病学特征分析
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jul 6;52(7):738-742. doi: 10.3760/cma.j.issn.0253-9624.2018.07.011.
9
The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.中国昆明使用肠道病毒 71 型灭活疫苗前后肠道病毒感染的流行病学特征。
Emerg Microbes Infect. 2021 Dec;10(1):619-628. doi: 10.1080/22221751.2021.1899772.
10
Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020.2006-2020 年西班牙手足口病和其他黏膜症状相关肠病毒监测。
Viruses. 2021 Apr 28;13(5):781. doi: 10.3390/v13050781.

引用本文的文献

1
Impact of meteorological factors on the incidence of hand, foot and mouth disease in Ningbo from 2014 to 2019: a causal convolutional neural networks.2014年至2019年气象因素对宁波手足口病发病率的影响:因果卷积神经网络
BMC Public Health. 2025 Jul 11;25(1):2434. doi: 10.1186/s12889-025-23634-y.
2
Mechanism research of Punicalagin in treating representative strains of enterovirus A and B types based on systems pharmacology and experimental validation.基于系统药理学和实验验证的石榴皮苷治疗A、B型肠道病毒代表性毒株的作用机制研究
Virol J. 2025 Jul 9;22(1):229. doi: 10.1186/s12985-025-02845-0.

本文引用的文献

1
Comparison of Neutralizing Antibody Response Kinetics in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017-2019.2017 - 2019年中国儿童肠道病毒A16型或肠道病毒A71型所致手足口病患者中和抗体反应动力学比较:一项纵向队列研究
J Immunol. 2022 Jul 15;209(2):280-287. doi: 10.4049/jimmunol.2200143. Epub 2022 Jul 1.
2
Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017.血清流行率和肠病毒 71 型和柯萨奇病毒 A6 的病毒学监测,英国,2006-2017 年。
Emerg Infect Dis. 2021 Sep;27(9):2261-2268. doi: 10.3201/eid2709.204915.
3
Antivirals blocking entry of enteroviruses and therapeutic potential.
抗病毒药物阻断肠道病毒进入及其治疗潜力。
J Biomed Sci. 2021 Jan 15;28(1):10. doi: 10.1186/s12929-021-00708-8.
4
Protecting the most vulnerable from hand, foot, and mouth disease.保护最弱势群体免受手足口病侵害。
Lancet Infect Dis. 2021 Mar;21(3):308-309. doi: 10.1016/S1473-3099(20)30452-7. Epub 2020 Oct 5.
5
Non-polio enteroviruses among healthy children in the Philippines.菲律宾健康儿童中的非脊灰肠道病毒。
BMC Public Health. 2020 Feb 3;20(1):167. doi: 10.1186/s12889-020-8284-x.
6
Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study.2015 年至 2017 年 24 个欧盟和欧洲经济区国家中非脊髓灰质炎肠道病毒的传播:一项回顾性监测研究。
Lancet Infect Dis. 2020 Mar;20(3):350-361. doi: 10.1016/S1473-3099(19)30566-3. Epub 2019 Dec 20.
7
Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study.2018 年美国科罗拉多州小儿肠病毒 A71 神经系统疾病爆发的临床特征:一项观察性队列研究。
Lancet Infect Dis. 2020 Feb;20(2):230-239. doi: 10.1016/S1473-3099(19)30632-2. Epub 2019 Dec 16.
8
Increased detection of enterovirus A71 infections, Germany, 2019.德国 2019 年肠道病毒 A71 感染的检出率上升。
Euro Surveill. 2019 Sep;24(39). doi: 10.2807/1560-7917.ES.2019.24.39.1900556.
9
Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016.2016 年西班牙与严重神经疾病相关的肠道病毒 A71 暴发的分子流行病学研究。
Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1800089.
10
Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.肠道病毒 A71 疫苗在中国北京针对有医疗就诊的手足口病病例中预防肠道病毒 A71 感染的效果。
Hum Vaccin Immunother. 2019;15(5):1183-1190. doi: 10.1080/21645515.2019.1581539. Epub 2019 Mar 20.